P2Y12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials.

Background

To assess the long term comparative effectiveness of P2Y12 inhibitor monotherapy compared with aspirin monotherapy in patients after percutaneous coronary intervention (PCI) and discontinuation of dual antiplatelet therapy (DAPT).

评估P2Y12抑制剂单药治疗与阿司匹林单药治疗在经皮冠状动脉介入治疗（PCI）后及双联抗血小板治疗（DAPT）停药后的长期比较有效性。